Cite
Allogeneic Stem Cell Transplant Shows Minimal OS, PFS Benefits in Patients With MM.
MLA
McNulty, Rose. “Allogeneic Stem Cell Transplant Shows Minimal OS, PFS Benefits in Patients With MM.” American Journal of Managed Care, Jan. 2023, pp. 18–19. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=161640294&authtype=sso&custid=ns315887.
APA
McNulty, R. (2023). Allogeneic Stem Cell Transplant Shows Minimal OS, PFS Benefits in Patients With MM. American Journal of Managed Care, 18–19.
Chicago
McNulty, Rose. 2023. “Allogeneic Stem Cell Transplant Shows Minimal OS, PFS Benefits in Patients With MM.” American Journal of Managed Care, January, 18–19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=161640294&authtype=sso&custid=ns315887.